Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Merlind Mücke

3PUBLICATIONS

71CO-AUTHORS

Molecular targetsTumour immunology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jul 13, 2026

A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

|Jun 12, 2026

Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control.

|Apr 07, 2026

A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.

Elena Garralda, Christoph Markert, Victor Moreno

Pageof 1

Frequent Collaborators

3 joint publications

Laura Codarri Deak

2 joint publications

Klas Hatje

2 joint publications

Christoph Markert

2 joint publications

Francesca Michielin

2 joint publications

Iakov I Davydov

2 joint publications

Vu-Long Tran

2 joint publications

Daniel Marbach

2 joint publications

Christine McIntyre

2 joint publications

Christian Heichinger

2 joint publications

Dominik Kraus

Frequent Collaborators

3 joint publications

Laura Codarri Deak

2 joint publications

Klas Hatje

2 joint publications

Christoph Markert

2 joint publications

Francesca Michielin